HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study-Reference-Cited by-同舟云学术

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study

Published:2019-01-16 Issue:1 Volume:16 Page:
ISSN:1742-6405
Container-title:AIDS Research and Therapy
language:en
Short-container-title:AIDS Res Ther

Author:

Mounzer Karam,Hsu Ricky,Fusco Jennifer S.,Brunet Laurence,Henegar Cassidy E.,Vannappagari Vani,Stainsby Chris M.,Shaefer Mark S.,Ragone Leigh,Fusco Gregory P.

Funder

ViiV Healthcare

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Virology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12981-019-0217-3.pdf

Reference27 articles.

1. Chittick GE, Gillotin C, McDowell JA, Lou Y, Edwards KD, Prince WT, et al. Abacavir: absolute bioavailability, bioequivalence of three oral formulations, and effect of food. Pharmacotherapy. 1999;19(8):932–42.

2. McDowell JA, Lou Y, Symonds WS, Stein DS. Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother. 2000;44(8):2061–7.

3. Weller S, Radomski KM, Lou Y, Stein DS. Population pharmacokinetics and pharmacodynamic modeling of abacavir (1592U89) from a dose-ranging, double-blind, randomized monotherapy trial with human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother. 2000;44(8):2052–60.

4. Wang LH, Chittick GE, McDowell JA. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection. Antimicrob Agents Chemother. 1999;43(7):1708–15.

5. Tisdale M, Alnadaf T, Cousens D. Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89. Antimicrob Agents Chemother. 1997;41(5):1094–8.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens–Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management;Chinese Medical Journal;2024-09-05

2. Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers in People Living with HIV/AIDS in Türkiye;Current HIV Research;2024-08-08

3. Dog leukocyte antigen genotyping across class I and class II genes in beagle dogs as laboratory animals;Immunogenetics;2024-06-26

4. Frequency distribution of HLA class I and II alleles in Greek population and their significance in orchestrating the National Donor Registry Program;International Journal of Immunogenetics;2024-03-08

5. HIV-1 Enfekte Bireylerde İnsan Lökosit Antijeni (HLA)-B*57:01 Pozitifliği Prevalansının Dağılımı ve Tedavi Üzerine Etkileri: Türkiye Haritası-BUHASDER Çalışma Grubu;Mikrobiyoloji Bulteni;2024-01-22